Citation map · Study

Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review

16 references·2 citing·38 second hop

this work references cited by second hop

References

2003Measuring inconsistency in meta-analyses63,086 cited
2009The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration28,094 cited
2003Evaluating non-randomised intervention studies2,905 cited
2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2,196 cited
2018Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States1,735 cited
2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial1,696 cited
2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study1,533 cited
2010Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer1,205 cited
2015Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study1,150 cited
2017Psilocybin with psychological support for treatment-resistant depression: six-month follow-up969 cited
2014Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction913 cited
2011Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness893 cited
2018Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

References

Cited by